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Abstract 
Purpose: To evaluate differences in the characteristics and outcomes of intensive care unit (ICU) patients over time.
Methods: We reviewed all epidemiological data, including comorbidities, types and severity of organ failure, inter‑
ventions, lengths of stay and outcome, for patients from the Sepsis Occurrence in Acutely ill Patients (SOAP) study, an 
observational study conducted in European intensive care units in 2002, and the Intensive Care Over Nations (ICON) 
audit, a survey of intensive care unit patients conducted in 2012.
Results: We compared the 3147 patients from the SOAP study with the 4852 patients from the ICON audit admitted 
to intensive care units in the same countries as those in the SOAP study. The ICON patients were older (62.5 ± 17.0 vs. 
60.6 ± 17.4 years) and had higher severity scores than the SOAP patients. The proportion of patients with sepsis at any 
time during the intensive care unit stay was slightly higher in the ICON study (31.9 vs. 29.6%, p = 0.03). In multilevel 
analysis, the adjusted odds of ICU mortality were significantly lower for ICON patients than for SOAP patients, particu‑
larly in patients with sepsis [OR 0.45 (0.35–0.59), p < 0.001].
Conclusions: Over the 10‑year period between 2002 and 2012, the proportion of patients with sepsis admitted to 
European ICUs remained relatively stable, but the severity of disease increased. In multilevel analysis, the odds of ICU 
mortality were lower in our 2012 cohort compared to our 2002 cohort, particularly in patients with sepsis.
Keywords: Epidemiology, Severity of disease, Sepsis
Introduction
Intensive care medicine is a relatively new specialty, but 
one that has evolved considerably over its short exist-
ence. Over the last 15 years or so, improved understand-
ing of underlying disease pathogenesis and the role of 
“iatrogenic” complications has led to key changes in man-
agement and process of care in intensive care unit (ICU) 
patients, including use of lower tidal volume ventilation, 
more restrictive blood transfusion practice, and less 
sedation, which may have helped reduce mortality rates. 
Conversely, the aging world population with increased 
comorbidity, increased use of chemotherapy and immuno-
suppression, and medical advances that enable an increas-
ing number of chronically ill patients to survive into old 
age, may favor admission of a sicker cohort of patients to 
the ICU and thus result in increased mortality rates.
Sepsis remains a leading cause of death worldwide among 
critically ill patients [1]. Although several recent studies have 
reported a substantial increase in the number of cases of 
sepsis per year, with a decrease in mortality of these patients 
[1, 2], this may largely be a reporting phenomenon associ-
ated with more complete capture of less ill patients [3, 4].
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To assess the changing epidemiology of ICU patients, 
and of sepsis in particular, we compared two large multi-
national observational studies conducted on ICU patients 
exactly 10 years apart, the Sepsis Occurrence in Acutely 
ill Patients (SOAP) study conducted in 2002 [5] and the 
larger worldwide Intensive Care Over Nations (ICON) 
audit conducted in 2012 [6]. The data collected for the 
two studies were almost identical and analysis was con-
ducted in the same center, facilitating comparisons and 
reducing the risk of bias. We hypothesized that patients 
in the current ICON era would be sicker but have lower 
mortality rates than patients in the SOAP study.
Methods
The SOAP study was conducted in 24 European countries 
and included 3147 patients [5]. The ICON audit included 
10,069 patients from 82 countries worldwide [6]. For 
the purposes of this comparison, we considered only 
the patients from ICON who were admitted to the same 
24 European countries as in the SOAP study (e-Table 1, 
e-Appendix). For both studies, recruitment for partici-
pation was by open invitation, through national scien-
tific societies, national and international meetings, and 
individual contacts. Participation was entirely voluntary, 
with no financial incentive. Institutional review board 
approval for both studies was obtained by the participat-
ing institutions according to local ethical regulations.
Participating ICUs (see e-Appendix) were asked to 
prospectively collect data on all adult patients admitted 
between May 1 and 15, 2002 for the SOAP study and 
between May 8 and 18, 2012 for the ICON audit. In both 
studies, patients who stayed in the ICU for  <  24  h for 
routine postoperative surveillance were not considered. 
Re-admissions of previously included patients were also 
not included. Data were collected daily during the ICU 
stay for a maximum of 28  days. Patients were followed 
up for outcome data until death, hospital discharge or for 
60 days.
Data were collected by the investigators using pre-
printed (for SOAP) and electronic (for ICON) case report 
forms. Data collection on admission included demo-
graphic data and comorbid diseases as well as source 
and reason for admission. Clinical and laboratory data 
for SAPS II [7] scores were reported as the worst values 
within 24  h after admission. The presence of microbio-
logically confirmed and clinically suspected infections 
was reported daily as were the antibiotics administered. 
A daily evaluation of organ function was performed using 
the sequential organ failure assessment (SOFA) score [8].
Definitions
Sepsis was defined as the presence of infection with the 
concomitant occurrence of at least one organ failure 
(defined as a SOFA score > 2 for the organ in question) 
in ICON, equivalent to the definition of “severe sepsis” 
used in SOAP. For the purposes of this comparison, we 
used this ICON definition of sepsis, recently supported 
by international consensus [9].
Data management and quality control
Detailed instructions explaining the aim of the study, 
instructions for data collection, and definitions were 
available through a secured website for all participants 
before starting data collection and throughout the study 
period. Additional queries were answered on a per case 
basis by the coordinating center during data collection. 
Data were further reviewed by the coordinating center 
for plausibility and availability of the outcome parameter, 
and any doubts were clarified with the center in question. 
There was no on-site monitoring. Missing data repre-
sented < 6% of the data collected for SOAP and 6.1% of 
the ICON data.
Statistical analysis
All data were processed and analyzed in the Department 
of Intensive Care of Erasme Hospital, University of Brus-
sels, in collaboration with Jena University Hospital, Jena, 
Germany. Data were analyzed using  IBM®  SPSS® Statis-
tics software, v.24 for Windows (IBM, Somers, NY, USA).
Data are summarized using means with standard 
deviation, medians and interquartile ranges, or numbers 
and percentages. Difference testing between groups was 
performed using Student’s t test, Mann–Whitney test, 
Chi square test or Fisher’s exact test, as appropriate. The 
Kolmogorov–Smirnov test was used, and histograms and 
quantile–quantile plots were examined to verify whether 
there were significant deviations from the normality 
assumption of continuous variables.
To identify the effect of being in the SOAP or ICON 
study on ICU mortality, and because of the hierarchical 
structure of the data, we performed a multivariable anal-
ysis using a multilevel binary logistic model with three 
levels: patient (level 1), admitted to a hospital (level 2), 
within a country (level 3). The dependent variable was 
ICU mortality. The explanatory variables considered in 
Take-home message 
This comparison of two databases created 10 years apart shows 
that ICU populations in Europe have changed over time. ICU patient 
are now slightly older and more severely ill. The number of patients 
with shock has increased as has the use of renal replacement thera‑
pies, whereas the proportion of patients receiving mechanical ven‑
tilation has decreased. ICU length of stay has remained unchanged 
and ICU mortality rates may have decreased.
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the model were age, sex, SAPS II score without age com-
ponent, type of admission, source of admission, treat-
ment with mechanical ventilation or renal replacement 
therapy (RRT), presence of sepsis, comorbidities and the 
study to which the patient belonged, i.e., SOAP or ICON.
For parameter testing, the likelihood-ratio test was 
used. Colinearity between variables was checked by 
inspection of the correlation between them, looking 
at the correlation matrix of the estimated parameters. 
The interaction between explanatory variables was also 
tested. Three models were constructed: the first model, 
an unconditional model with no exposure factors, was 
used to discern the amount of variance that existed 
between hospital and country levels; the second model 
(the unadjusted model) contained the study to which the 
patient belonged, presence of sepsis and their interaction; 
and the third model (the adjusted model) was extended 
to include the other patient characteristics. The results 
of the fixed effects (measures of association) are given 
as odds ratios (ORs) with their 95% CIs. A second order 
penalized quasi-likelihood (PQL) estimation method 
was used, because this method approximates well com-
pared to other methods [10]. The statistical significance 
of covariates was calculated using the Wald test. No sta-
tistical adjustments were used for multiple testing. All 
reported p values are two-sided and a p value of less than 
0.05 was considered to indicate statistical significance.
Results
We compared the 3147 patients from the SOAP study 
with the 4852 patients from the ICON audit who were 
admitted to ICUs in the same countries as the patients in 
the SOAP study. The number of centers and number of 
patients in each country is shown in e-Table 1, the main 
differences being that a smaller proportion of patients 
were included from Belgium and France in ICON than in 
SOAP and a larger proportion from the UK and Spain.
The characteristics of the two patient populations 
are shown in Tables  1 and 2. ICON patients were older 
(62.5 ± 17.0 vs. 60.6 ± 17.4 years, p < 0.001) than SOAP 
patients and more likely to have co-morbid chronic 
obstructive pulmonary disease (COPD) and insulin-
dependent diabetes mellitus. They were more likely to be 
receiving chemotherapy on admission and less likely to be 
receiving corticosteroids. ICON patients were more likely 
to have circulatory shock, respiratory failure and/or liver 
failure on admission than SOAP patients. They had higher 
SAPS II scores (41.9 ± 18.2 vs. 36.5 + 17.1) on admission, 
higher SOFA scores on admission (6.3 ± 4.3 vs. 5.1 ± 3.8) 
and higher max SOFA scores during the ICU stay (7.8 ± 4.8 
vs. 6.6 ± 4.4) than the SOAP patients (all p < 0.001).
ICON patients were less likely to receive invasive 
mechanical ventilation during their ICU stay (59.3 vs. 
64.3%, p < 0.001) but more likely to be treated with renal 
replacement therapy (RRT; 12.7 vs. 9.7%, p  <  0.001). 
There was a small increase in the proportion of patients 
with sepsis at any time during the ICU stay between the 
two studies (29.6% in SOAP vs. 31.9% in ICON, p = 0.03). 
Gram-negative pathogens were more frequently isolated 
(66.3 vs. 60.2%, p =  0.01) and fungi less frequently iso-
lated (14.8 vs. 20.7%, p < 0.001) in infected ICON patients 
than in infected SOAP patients (e-Table 2).
The ICU lengths of stay were not significantly differ-
ent in the two studies, but the overall ICU mortality rate 
was slightly lower in ICON than in SOAP (16.8 vs. 18.5%, 
p  =  0.05). Hospital (24.1% in SOAP vs. 23.9 in ICON, 
p = 0.83) and 60-day (23.4% in SOAP vs. 23.7 in ICON, 
p = 0.75) mortality rates were not different between the 
studies. The improvement in ICU survival was particu-
larly notable in patients with sepsis, shock or liver failure 
on admission or during the ICU stay, and those with renal 
failure during the ICU admission (Table 2). ICU mortality 
rates were significantly lower in ICON for all degrees of 
organ failure on admission (Fig. 1) and for all numbers of 
failing organs during the ICU admission (Table 2). Similar 
patterns in ICU mortality rates were identified in patients 
with and without sepsis (e-Tables 3 and 4, e-Figure 1).
In multilevel analysis, the  adjusted odds of ICU mor-
tality were significantly lower for ICON patients than for 
SOAP patients, both with and without sepsis (Table  3). 
Interestingly, the reduced odds were greater for patients 
with sepsis than for those without in both non-adjusted 
(p  =  0.016) and adjusted (p  =  0.006) analyses. The 
unconditional model indicated significant between-
country (var 0.21, p = 0.015) and between-hospital (var 
0.23, p < 0.001) variations in the individual risk of in-ICU 
death (Table 3). After controlling for patient factors, the 
differences across hospitals remained statistically sig-
nificant (var 0.29, p < 0.0001); in contrast, the differences 
across countries disappeared after adjustment (var 0.06, 
p = 0.23).
Discussion
This comparison of two databases created 10 years apart 
shows some important epidemiological differences 
in ICU populations in Europe over time. The number 
of patients with shock has increased as has the use of 
renal replacement therapies, whereas the proportion of 
patients receiving mechanical ventilation has decreased. 
Although ICU patient populations are slightly older and 
more severely ill, ICU survival rates have improved even 
after adjustment for multiple potential confounders.
The proportion of patients receiving invasive mechani-
cal ventilation decreased over the 10-year period. Indeed, 
although the proportion of patients with respiratory fail-
ure at ICU admission was greater in ICON than in SOAP, 
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Table 1 Characteristics of the two cohorts of patients
Percentages were calculated after exclusion of missing values
RRT renal replacement therapy, ICU intensive care unit, SAPS simplified acute physiology score, SOFA sequential organ failure assessment, ER emergency room, OR 
operating room, COPD chronic obstructive pulmonary disease, HIV human immunodeficiency virus, AIDS acquired immunodeficiency syndrome
SOAP (2002), n = 3147 ICON (2012), n = 4852 p value
Age, years, mean ± SD 60.6 ± 17.4 62.5 ± 17.0 < 0.001
Male, n (%) 1920 (61.7) 2924 (61.0) 0.53
Severity scores, mean ± SD
 SAPS II score 36.5 ± 17.1 41.9 ± 18.2 < 0.001
 SAPS II score without age 26.0 ± 16.1 30.8 ± 17.0 < 0.001
 SOFA score at admission 5.1 ± 3.8 6.3 ± 4.3 < 0.001
 Max SOFA score 6.6 ± 4.4 7.8 ± 4.8 < 0.001
Type of admission, n (%) < 0.001
 Surgical 1388 (44.1) 2075 (45.4)
  Elective 778 (24.7) 776 (17.0)
  Emergency 610 (19.4) 1076 (23.6)
 Medical 1759 (55.9) 2459 (53.9)
 Other 0 (0.0) 30 (0.7)
Source of admission, n (%)
 Other hospital 345 (11.0) 446 (9.2) < 0.001
 ER/ambulance 913 (29.0) 1758 (36.2)
 OR/recovery room 784 (24.9) 910 (18.8)
 Hospital floor 793 (25.2) 1378 (28.4)
 Other 312 (9.9) 360 (7.4)
Comorbidities, n (%)
 COPD 340 (10.8) 743 (15.3) < 0.001
 Cancer 415 (13.2) 568 (11.7) 0.05
 Metastatic cancer 105 (3.3) 160 (3.3) 1.00
 Hematologic cancer 69 (2.2) 122 (2.5) 0.37
 Insulin‑dependent diabetes 226 (7.2) 451 (9.3) 0.001
 Heart failure, NYHA III/IV 307 (9.8) 493 (10.2) 0.57
 HIV/AIDS 26 (0.9) 24 (0.5) 0.08
 Cirrhosis 121 (3.8) 205 (4.2) 0.42
 Steroid therapy 165 (5.2) 201 (4.1) 0.03
 Chemotherapy 25 (0.8) 121 (2.5) < 0.001
Procedures/events on admission, n (%)
 Mechanical ventilation 1850 (58.8) 2572 (53.0) < 0.001
 RRT 115 (3.7) 242 (5.0) < 0.01
 Sepsis 552 (17.5) 894 (18.4) 0.31
Procedures/events during the ICU stay, n (%)
 Central venous catheter 2272 (72.2) 3143 (64.8) < 0.001
 Pulmonary artery catheter 481 (15.3) 729 (15.0) 0.751
 Mechanical ventilation 2025 (64.3) 2875 (59.3) < 0.001
 RRT 306 (9.7) 615 (12.7) < 0.001
 Sepsis 930 (29.6) 1546 (31.9) 0.03
Outcomes
ICU stay, median (IQR) 3.0 (1.7–6.9) 3.0 (2.0–7.0) 0.31
 Survivors 3.0 (1.8–6.6) 3.0 (2.0–6.0) 0.57
 Non‑survivors 3.3 (1.2–9.8) 3.0 (1.0–9.0) 0.20
ICU mortality, n (%) 583 (18.5) 796 (16.8) 0.05
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the proportion during the ICU stay was lower. Moreo-
ver, we can speculate that more patients with respiratory 
failure are now managed using non-invasive mechanical 
ventilation [11] and/or high-flow nasal cannula oxygen 
[12]. We chose not to record data on non-invasive ven-
tilation as it is difficult to evaluate over 24-h periods. It 
is also possible that mechanical ventilation was more 
frequently withheld in the ICON cohort; however, the 
decreased mortality rate in a sicker cohort of patients 
argues against this possibility. In contrast to the reduced 
use of mechanical ventilation, there was an increased 
use of RRT in the ICON population, as expected with 
the larger proportion of patients with renal failure dur-
ing the ICU stay. Sakhuja et al. also recently reported an 
increased incidence of acute kidney injury requiring dial-
ysis in patients with sepsis between 2000 and 2009 [13].
A number of studies have reported that the incidence of 
sepsis has increased dramatically over time. However, as 
suggested by Rhee et al. [14], this may be largely a reporting 
phenomenon associated with financial reimbursement or 
increasing awareness of and familiarity with sepsis-related 
definitions and coding among medical staff [15–17]. Using 
clinical data alone, these same authors recently reported 
no increase in sepsis incidence between 2009 and 2014 
in almost 8,000,000 admissions to US hospitals, although 
again incidence increased when sepsis was defined using 
ICD codes [18]. Our study also suggests that the rate of 
sepsis (as defined using the criteria of infection associated 
with organ dysfunction as in the most recent guidelines 
[9]) has remained relatively stable over the 10-year period. 
Martin et al. reported an increase in the severity of illness 
of patients with sepsis across US hospitals over a 22-year 
Table 2 Incidence and ICU mortality in the two cohorts according to the numbers and types of organ failures
Percentages were calculated after exclusion of missing values
a As defined by a SOFA score > 2 for the organ in question
Incidence, n (%) ICU mortality, n (%)
SOAP (2002) ICON (2012) p value (if < 0.05) SOAP (2002) ICON (2012) p value (if < 0.05)
Sepsis on admission 552 (17.5) 894 (18.4) 185 (33.5) 227 (25.6) 0.001
Type of organ  failurea on admission, n (%) (alone or in combination)
 Cardiovascular 776 (24.7) 1557 (32.1) < 0.001 278 (35.8) 428 (27.9) < 0.001
 Respiratory 696 (22.1) 1194 (24.6) 0.010 207 (29.7) 360 (30.5)
 CNS 683 (21.7) 1094 (22.5) 255 (37.3) 395 (37.1)
 Renal 575 (18.3) 898 (18.5) 173 (30.1) 300 (33.8)
 Coagulation 149 (4.7) 196 (4.0) 60 (40.3) 69 (36.1)
 Hepatic 85 (2.7) 440 (9.1) < 0.001 29 (34.1) 79 (18.4) 0.001
No of organ  failuresa on admission, n (%)
 None 1338 (42.5) 1834 (37.8) < 0.001 84 (6.3) 78 (6.0)
 1 organ 979 (31.1) 1476 (30.4) < 0.001 180 (18.4) 122 (11.3) < 0.001
 2 organs 564 (17.9) 915 (18.9) < 0.001 175 (31.0) 199 (25.8) 0.036
 3 organs 215 (6.8) 458 (9.4) < 0.001 111 (51.6) 166 (42.6) 0.033
 4 + organs 51 (1.6) 169 (3.5) < 0.001 33 (64.7) 87 (62.4)
Sepsis during the ICU stay 930 (29.6) 1546 (31.9) 0.029 299 (32.2) 386 (25.1) < 0.001
Type of organ  failurea during the ICU stay, n (%) (alone or in combination)
 Cardiovascular 1052 (33.4) 1978 (40.8) < 0.001 403 (38.3) 571 (29.3) < 0.001
 Respiratory 1301 (41.3) 1778 (36.6) < 0.001 393 (30.2) 548 (31.3)
 CNS 839 (26.7) 1374 (28.3) 347 (41.4) 529 (39.4)
 Renal 1120 (35.6) 2280 (47.0) < 0.001 338 (30.2) 559 (24.8) < 0.001
 Coagulation 309 (9.8) 451 (9.3) 141 (45.6) 178 (40.0)
 Hepatic 168 (5.3) 944 (19.5) < 0.001 65 (38.9) 185 (19.9) < 0.001
No of organ  failuresa during the ICU stay, n (%)
 None 903 (28.7) 1120 (23.1) < 0.001 17 (1.9) 35 (3.8) 0.017
 1 organ 994 (31.6) 1257 (25.9) < 0.001 71 (7.1) 32 (4.0) 0.004
 2 organs 717 (22.8) 955 (19.7) < 0.001 195 (27.2) 90 (13.0) < 0.001
 3 organs 368 (11.7) 744 (15.3) < 0.001 178 (48.5) 191 (30.4) < 0.001
 4 + organs 165 (5.2) 776 (16.0) < 0.001 122 (73.9) 304 (47.2) < 0.001
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period, but a decrease in hospital mortality from 27.8% 
in 1979–1984 to 17.9% in 1995–2000 [19]. Also in the 
US, Kumar et al. reported increasing severity of illness, as 
assessed by the mean number of organ system failures dur-
ing the ICU stay, during the period 2000–2007, but decreas-
ing mortality rates from 39 to 27% [20]. And Stoller et al. 
made similar findings during the period 2008–2012 [21]. In 
Spain, Bouza et al. reported a decrease in case fatality rates 
from 45 to 40% between 2006 and 2011, despite increas-
ing disease severity [22], and Kaukonen et al. [2] reported 
a decrease in mortality from 2000 to 2012 for patients with 
severe sepsis that persisted when adjusted for severity of 
illness. The decrease in mortality over time, particularly 
among patients with sepsis, parallel to the increase in dis-
ease severity, is an interesting phenomenon that has been 
reported previously [19–22], and suggests that progress has 
been made in the field of intensive care medicine. Indeed, 
multiple aspects of ICU patient management have changed 
over the last decade or so, including, among others, more 
widespread use of lower tidal volume ventilation [23], more 
restrictive blood transfusion practice [24], reduced sedative 
use [25] and earlier mobilization, and more rapid appropri-
ate intervention in patients with sepsis [26], some of which 
have been associated with improved outcomes. Of note, in-
hospital and 60-day mortality rates were not significantly 
different in our two cohorts. Our data do not enable us to 
determine the reasons for this observation, although it is 
interesting to speculate that ICU management may have 
improved more than post-ICU care.
The strengths of our study are the comparison of two 
large multicenter registries conducted 10 years apart in the 
same month of the year, and which prospectively included 
almost identical variables, analyzed in the same center. But 
our study also has important limitations. First, although 
data collection was prospective, our study was observational 
in nature and the analysis retrospective; we therefore can-
not discount that unmeasured factors may have confounded 
our results. Moreover, because of multiple comparisons, an 
inflated type 1 error may be possible. In addition, although 
we clearly demonstrate improved survival of critically ill 
patients over time, notwithstanding the increased sever-
ity of illness, we can only speculate on the mechanism of 
these improved outcomes. Indeed, the observed increased 
severity of illness may in part be related to changes in ICU 
admitting practices or in improved capabilities to care for 
patients in non-ICU settings. These are important areas of 
future research. Second, we do not have any information 
about end-of-life decisions or on outcomes after 60  days. 
We are also unable to comment on differences in the qual-
ity of life of the survivors. Return to reasonable physical, 
mental and cognitive functionality is an important aspect 
of patient-centered outcomes. Third, although we included 
centers from the same countries, we were unable to perform 
a center-by-center comparison. Over time, hospital names 
and networks have changed, making a direct comparison 
impractical. Moreover, we had no data to assess how rep-
resentative the participating hospitals were of their coun-
try. Finally, the SOAP study included patients over a longer 
period of time (15  days) than the ICON study (11  days). 
However, this is unlikely to have influenced the results.
Despite these limitations, the present observations 
show that ICU patients were sicker in our 2012 cohort 
than in our 2002 cohort. Multilevel analysis showed that 
survival was improved in the later cohort, especially for 
Fig. 1 Percentage of patients (left panel) and ICU mortality rates (right panel) in ICON (2012) and SOAP (2002) studies according to sequential 
organ failure assessment (SOFA) scores on admission (upper panel) and Simplified Acute Physiology Score (SAPS) II (lower panel)
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patients with sepsis. These results are encouraging and 
suggest that progress has been made in the field of inten-
sive care medicine over just a 10-year period.
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Table 3 Summary of multilevel analysis with ICU mortality as the dependent variable
The interaction between sepsis/non-sepsis and SOAP/ICON is significant
a Without age component
Variables Model 1 Model 2 p value Model 3 p value
OR (95% CI) OR (95% CI) OR (95% CI)
Fixed‑effects, varying within clusters
 Age – – 1.02 (1.02–1.03) < 0.001
 Sex, male – – 0.92 (0.85–1.00) 0.037
 SAPSIIa – – 1.06 (1.06–1.07) < 0.001
Type of admission (%)
 Surgical – –
 Medical – – 1.49 (1.22–1.82) < 0.001
 Other – – 1.81 (1.09–2.98) 0.021
Source of admission
 OR/recovery – –
 Other hospital – – 1.17 (0.88–1.57) 0.282
 ER/ambulance – – 1.31 (1.13–1.53) 0.001
 Hospital floor – – 1.47 (1.18–1.84) 0.001
 Other – – 1.42 (0.98–2.06) 0.062
Comorbidities
 COPD – – 1.07 (0.90–1.28) 0.423
 Cancer – – 1.25 (1.00–1.55) 0.050
 Insulin‑dependent diabetes – – 0.72 (0.57–0.92) 0.008
 Heart failure, NYHA III/IV – – 1.22 (1.00–1.49) 0.053
 HIV infection 1.38 (0.78–2.44) 0.271
 Cirrhosis 2.15 (1.70–2.71) <0.001
Procedures
 Mechanical ventilation – – 3.57 (2.57–4.95) < 0.001
 Renal replacement therapy – – 1.86 (1.51–2.30) < 0.001
Study (ICON vs. SOAP)
 Non‑sepsis 0.95 (0.77–1.17) 0.611 0.64 (0.53–0.77) < 0.001
 Sepsis 0.70 (0.54–0.91) 0.009 0.45 (0.35–0.59) < 0.001
Random‑effects
 Country
  Variance (SE) 0.21 (0.09) 0.14 (0.07) 0.06 (0.05)
  p value 0.015 0.033 0.229
 Centers
  Variance 0.23 (0.05) 0.23 (0.05) 0.29 (0.07)
 p value < 0.001 < 0.001 < 0.001
344
Author contributions
JLV designed the study, analyzed the data and drafted the article; YS partici‑
pated in the original ICON and SOAP studies, helped analyze the data and 
draft the article; JYL, KK, RN, IML, XW, SGS, and PP participated in the original 
ICON study and revised the article for critical content; RM participated in the 
original SOAP study and revised the article for critical content. All authors read 
and approved the final manuscript.
Compliance with ethical standards
Conflicts of interest
The authors have no conflicts of interest to declare.
Open Access
This article is distributed under the terms of the Creative Commons Attribu‑
tion‑NonCommercial 4.0 International License (http://creativecommons.org/
licenses/by‑nc/4.0/), which permits any noncommercial use, distribution, and 
reproduction in any medium, provided you give appropriate credit to the 
original author(s) and the source, provide a link to the Creative Commons 
license, and indicate if changes were made.
Received: 17 October 2017   Accepted: 29 December 2017
Published online: 15 February 2018
References
 1. Kadri SS, Rhee C, Strich JR, Morales MK, Hohmann S, Menchaca J, Suf‑
fredini AF, Danner RL, Klompas M (2016) Estimating ten‑year trends in 
septic shock incidence and mortality in United States academic medical 
centers using clinical data. Chest 151:278–285
 2. Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R (2014) Mortality 
related to severe sepsis and septic shock among critically ill patients in 
Australia and New Zealand, 2000–2012. JAMA 311:1308–1316
 3. Rhee C, Gohil S, Klompas M (2014) Regulatory mandates for sepsis care‑
reasons for caution. N Engl J Med 370:1673–1676
 4. Vincent JL, Mira JP, Antonelli M (2016) Sepsis: older and newer concepts. 
Lancet Respir Med 4:237–240
 5. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno 
R, Carlet J, Le Gall JR et al (2006) Sepsis in European intensive care units: 
results of the SOAP study. Crit Care Med 34:344–353
 6. Vincent JL, Marshall JC, Namendys‑Silva SA, Francois B, Martin‑Loeches 
I, Lipman J, Reinhart K, Antonelli M, Pickkers P et al (2014) Assessment of 
the worldwide burden of critical illness: the Intensive Care Over Nations 
(ICON) audit. Lancet Respir Med 2:380–386
 7. Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiol‑
ogy score (SAPS II) based on a European/North American multicenter 
study. JAMA 270:2957–2963
 8. Vincent JL, Moreno R, Takala J, Willatts S, de Mendonça A, Bruining H, 
Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (sepsis‑related organ 
failure assessment) score to describe organ dysfunction/failure. Intensive 
Care Med 22:707–710
 9. Singer M, Deutschman CS, Seymour CW, Shankar‑Hari M, Annane D, 
Bauer M, Bellomo R, Bernard GR, Chiche JD et al (2016) The third interna‑
tional consensus definitions for sepsis and septic shock (sepsis‑3). JAMA 
315:801–810
 10. Goldstein H (2003) Multilevel statistical models. Hodder Arnold, London
 11. Demoule A, Chevret S, Carlucci A, Kouatchet A, Jaber S, Meziani F, 
Schmidt M, Schnell D, Clergue C et al (2016) Changing use of noninvasive 
ventilation in critically ill patients: trends over 15 years in francophone 
countries. Intensive Care Med 42:82–92
 12. Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, Prat G, Boulain T, 
Morawiec E et al (2015) High‑flow oxygen through nasal cannula in acute 
hypoxemic respiratory failure. N Engl J Med 372:2185–2196
 13. Sakhuja A, Kumar G, Gupta S, Mittal T, Taneja A, Nanchal RS (2015) Acute 
kidney injury requiring dialysis in severe sepsis. Am J Respir Crit Care Med 
192:951–957
 14. Rhee C, Murphy MV, Li L, Platt R, Klompas M (2015) Comparison of trends 
in sepsis incidence and coding using administrative claims versus objec‑
tive clinical data. Clin Infect Dis 60:88–95
 15. Epstein L, Dantes R, Magill S, Fiore A (2016) Varying estimates of sepsis 
mortality using death certificates and administrative codes—United 
States, 1999–2014. Morb Mortal Wkly Rep 65:342–345
 16. Bouza C, Lopez‑Cuadrado T, Amate‑Blanco JM (2016) Use of explicit ICD9‑
CM codes to identify adult severe sepsis: impacts on epidemiological 
estimates. Crit Care 20:313
 17. Gohil SK, Cao C, Phelan M, Tjoa T, Rhee C, Platt R, Huang SS (2016) Impact 
of policies on the rise in sepsis incidence, 2000–2010. Clin Infect Dis 
62:695–703
 18. Rhee C, Dantes R, Epstein L, Murphy DJ, Seymour CW, Iwashyna TJ, Kadri 
SS, Angus DC, Danner RL et al (2017) Incidence and trends of sepsis in US 
hospitals using clinical vs claims data, 2009–2014. JAMA 318:1241–1249
 19. Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology 
of sepsis in the United States from 1979 through 2000. N Engl J Med 
348:1546–1554
 20. Kumar G, Kumar N, Taneja A, Kaleekal T, Tarima S, McGinley E, Jimenez E, 
Mohan A, Khan RA, Whittle J, Jacobs E, Nanchal R; Milwaukee Initiative in 
Critical Care Outcomes Research (MICCOR) Group of Investigators (2011) 
Nationwide trends of severe sepsis in the 21st century (2000–2007). 
Chest 140:1223–1231
 21. Stoller J, Halpin L, Weis M, Aplin B, Qu W, Georgescu C, Nazzal M (2016) 
Epidemiology of severe sepsis: 2008–2012. J Crit Care 31:58–62
 22. Bouza C, Lopez‑Cuadrado T, Saz‑Parkinson Z, Amate‑Blanco JM (2014) 
Epidemiology and recent trends of severe sepsis in Spain: a nationwide 
population‑based analysis (2006–2011). BMC Infect Dis 14:3863
 23. The Acute Respiratory Distress Syndrome Network (2000) Ventilation with 
lower tidal volumes as compared with traditional tidal volumes for acute 
lung injury and the acute respiratory distress syndrome. N Engl J Med 
342:1301–1308
 24. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, 
Tweeddale M, Schweitzer I, Yetisir E (1999) A multicenter, randomized, 
controlled clinical trial of transfusion requirements in critical care. Transfu‑
sion Requirements in Critical Care Investigators, Canadian Critical Care 
Trials Group. N Engl J Med 340:409–417
 25. Baron R, Binder A, Biniek R, Braune S, Buerkle H, Dall P, Demirakca S, 
Eckardt R, Eggers V et al (2015) Evidence and consensus based guideline 
for the management of delirium, analgesia, and sedation in intensive care 
medicine. Revision 2015 (DAS‑Guideline 2015)—short version. Ger Med 
Sci 13:Doc19
 26. Miller RR III, Dong L, Nelson NC, Brown SM, Kuttler KG, Probst DR, Allen TL, 
Clemmer TP (2013) Multicenter implementation of a severe sepsis and 
septic shock treatment bundle. Am J Respir Crit Care Med 188:77–82
